Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1967 1
1971 1
1973 2
1974 1
1975 1
1976 3
1977 4
1978 1
1979 3
1980 6
1982 3
1983 5
1984 8
1985 10
1986 9
1987 10
1988 13
1989 25
1990 17
1991 18
1992 25
1993 22
1994 26
1995 35
1996 30
1997 30
1998 45
1999 44
2000 56
2001 50
2002 40
2003 62
2004 66
2005 58
2006 74
2007 82
2008 99
2009 109
2010 105
2011 126
2012 134
2013 159
2014 150
2015 141
2016 141
2017 123
2018 128
2019 121
2020 131
2021 117
2022 95
2023 86
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

2,569 results

Results by year

Filters applied: . Clear all
Page 1
Survival Analysis of Glioblastoma Multiforme.
Witthayanuwat S, Pesee M, Supaadirek C, Supakalin N, Thamronganantasakul K, Krusun S. Witthayanuwat S, et al. Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2613-2617. doi: 10.22034/APJCP.2018.19.9.2613. Asian Pac J Cancer Prev. 2018. PMID: 30256068 Free PMC article.
Introduction: To evaluate the survival of Glioblastoma Multiforme (GBM). Material and Methods: Patients with a pathological diagnosis of Glioblastoma Multiforme (GBM) between 1 January 1994 and 30 November 2013, were retrospectively reviewed. ...
Introduction: To evaluate the survival of Glioblastoma Multiforme (GBM). Material and Methods: Patients with a pathological di …
Immune check-point in glioblastoma multiforme.
De Felice F, Pranno N, Marampon F, Musio D, Salducci M, Polimeni A, Tombolini V. De Felice F, et al. Crit Rev Oncol Hematol. 2019 Jun;138:60-69. doi: 10.1016/j.critrevonc.2019.03.019. Epub 2019 Apr 4. Crit Rev Oncol Hematol. 2019. PMID: 31092387 Review.
Glioblastoma multiforme (GBM) represents one of the main frequent and aggressive primary brain neoplasms among adults worldwide. ...
Glioblastoma multiforme (GBM) represents one of the main frequent and aggressive primary brain neoplasms among adults worldwid …
Imaging glioblastoma multiforme.
Nelson SJ, Cha S. Nelson SJ, et al. Cancer J. 2003 Mar-Apr;9(2):134-45. doi: 10.1097/00130404-200303000-00009. Cancer J. 2003. PMID: 12784879 Review.
Glioblastoma multiforme are infiltrative lesions that have a high degree of heterogeneity, both within and between different patients. ...As the molecular properties that influence invasion and neoplastic transformation are elucidated, it is critical that noninvasiv …
Glioblastoma multiforme are infiltrative lesions that have a high degree of heterogeneity, both within and between different p …
Inflammatory Mediators and GBM Malignancy: Current Scenario and Future Prospective.
Ulasov I, Singh V, Laevskaya A, Timashev P, Kharwar RK. Ulasov I, et al. Discov Med. 2023 Aug;35(177):458-475. doi: 10.24976/Discov.Med.202335177.47. Discov Med. 2023. PMID: 37553300 Review.
Glioblastoma multiforme is one of the most widespread and dangerous forms of brain tumor with high inflammation. ...Inflammatory mediators like chemokines, cytokines, and growth factors possibly serve as a capable therapeutic target to quash their tumor-promoting pr …
Glioblastoma multiforme is one of the most widespread and dangerous forms of brain tumor with high inflammation. ...Inflammato …
Nomograms for prognostic risk assessment in glioblastoma multiforme: Applications and limitations.
Zheng H, Yan T, Han Y, Wang Q, Zhang G, Zhang L, Zhu W, Xie L, Guo X. Zheng H, et al. Clin Genet. 2022 Nov;102(5):359-368. doi: 10.1111/cge.14200. Epub 2022 Aug 1. Clin Genet. 2022. PMID: 35882630 Review.
Glioblastoma multiforme (GBM) is the most common and aggressive form of brain cancer. ...
Glioblastoma multiforme (GBM) is the most common and aggressive form of brain cancer. ...
Proton radiotherapy for glioma and glioblastoma.
Goff KM, Zheng C, Alonso-Basanta M. Goff KM, et al. Chin Clin Oncol. 2022 Dec;11(6):46. doi: 10.21037/cco-22-92. Chin Clin Oncol. 2022. PMID: 36632979 Free article. Review.
Radiotherapy (RT) continues to be an important component of treatment of glioma, particularly high-grade glioma and glioblastoma multiforme (GBM). GBM is one of the most aggressive central nervous system (CNS) tumors, with high rates of recurrence and very low rates …
Radiotherapy (RT) continues to be an important component of treatment of glioma, particularly high-grade glioma and glioblastoma m …
Mesenchymal stem cells: a trojan horse to treat glioblastoma.
Chartouni A, Mouawad A, Boutros M, Attieh F, Medawar N, Kourie HR. Chartouni A, et al. Invest New Drugs. 2023 Apr;41(2):240-250. doi: 10.1007/s10637-023-01352-9. Epub 2023 Apr 5. Invest New Drugs. 2023. PMID: 37017885 Review.
Glioblastoma multiforme (GBM) is the most common and lethal primary tumor of the central nervous system. ...Some of these agents are: chemotherapy drugs, prodrug activating therapy, oncolytic viruses, nanoparticles, human artificial chromosome Promising results have …
Glioblastoma multiforme (GBM) is the most common and lethal primary tumor of the central nervous system. ...Some of these agen …
DCVax®-L--developed by Northwest Biotherapeutics.
Polyzoidis S, Ashkan K. Polyzoidis S, et al. Hum Vaccin Immunother. 2014;10(11):3139-45. doi: 10.4161/hv.29276. Hum Vaccin Immunother. 2014. PMID: 25483653 Free PMC article. Review.
Dendritic cell (DC) immunotherapy is emerging as a potential addition to the standard of care in the treatment of glioblastoma multiforme (GBM). In the last decade or so various research groups have conducted phase I and II trials of DC-immunotherapy on patients wit …
Dendritic cell (DC) immunotherapy is emerging as a potential addition to the standard of care in the treatment of glioblastoma mul …
Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
Deng X, Sun X, Hu Z, Wu Y, Zhou C, Sun J, Gao X, Huang Y. Deng X, et al. FASEB J. 2023 Sep;37(9):e23155. doi: 10.1096/fj.202301343. FASEB J. 2023. PMID: 37606566
Although the role of N6-Methyladenosine (m6A) methylation factors has been established in multiple cancer types, its involvement in glioblastoma multiforme (GBM) remains limited. This study aims to explore the involvement of m6A regulators in GBM and examine their a …
Although the role of N6-Methyladenosine (m6A) methylation factors has been established in multiple cancer types, its involvement in gliob …
Scaffold-based spheroid models of glioblastoma multiforme and its use in drug screening.
Manikandan C, Jaiswal AK. Manikandan C, et al. Biotechnol Bioeng. 2023 Aug;120(8):2117-2132. doi: 10.1002/bit.28481. Epub 2023 Jun 27. Biotechnol Bioeng. 2023. PMID: 37366303 Review.
Among several types of brain cancers, glioblastoma multiforme (GBM) is a terminal and aggressive disease with a median survival of 15 months despite the most intensive surgery and chemotherapy. ...
Among several types of brain cancers, glioblastoma multiforme (GBM) is a terminal and aggressive disease with a median surviva …
2,569 results